Evidence map›Paper›PMID 35959501›Full record

ArticleJournal of clinical orthopaedics and trauma2022

The influence of site on the incidence and diagnosis of solitary central cartilage tumours of the femur. A 21

A M Davies, A Patel, C Azzopardi, S L James, R Botchu, L Jeys

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical orthopaedics and trauma, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. [Primary malignant bone tumours-part II].Radiologie (Heidelberg, Germany) · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

A M DaviesDepartment of Musculoskeletal Imaging, Royal Orthopaedic Hospital, Birmingham, UK.
A PatelDepartment of Musculoskeletal Imaging, Royal Orthopaedic Hospital, Birmingham, UK.
C AzzopardiDepartment of Musculoskeletal Imaging, Royal Orthopaedic Hospital, Birmingham, UK.
S L JamesDepartment of Musculoskeletal Imaging, Royal Orthopaedic Hospital, Birmingham, UK.
R BotchuDepartment of Musculoskeletal Imaging, Royal Orthopaedic Hospital, Birmingham, UK.
L JeysDepartments of Orthopaedic Oncology, Royal Orthopaedic Hospital, Birmingham, UK.
Royal Orthopaedic Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To determine the incidence of central cartilage tumours (CCTs) in the femur and the impact of site (proximal, mid and distal thirds) on tumour grade. To compare study results with historically published data. Materials and methods: Retrospective review of solitary CCTs arising in the femur over the past 13 years. Data collected included location (proximal, mid and distal thirds) and final diagnosis in terms of tumour grade based on imaging features ± histology. Case material collected from three bone tumour textbooks provided historical data. Results: 430 solitary CCTs were included in the femur. 73% cases arose in the distal, 3.7% in the mid and 23% in the proximal femur. The ratio of "benign" (combining enchondroma and atypical cartilaginous tumour (ACT)) to higher grade chondrosarcoma (CS) was 11:1 in the distal, 1:1 in the mid and 1:1.5 in the proximal femur, the distribution of benign to malignant tumours being significantly different between the regions (F test, p < 0.05). Comparison with historical data showed a reversal of the benign (enchondroma) to malignant (ACT and higher grade CS) of 30%:70%-84%:16% in the current series. Conclusions: The site of origin of a CCT in the femur has an impact on final diagnosis with CS uncommon in the distal as compared with the mid and proximal femur. This is in contradistinction to historical data where the incidence of CS exceeded that of enchondroma at all sites.

Indexed as

Central cartilage tumourFemurSolitary

Identifiers

PMID35959501
PMCPMC9358228
OpenAlexW4288886239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.